Opportunities, Challenges and Benefits of using HACCP as a Quality Risk Management Tool in the Pharmaceutical Industry

Size: px
Start display at page:

Download "Opportunities, Challenges and Benefits of using HACCP as a Quality Risk Management Tool in the Pharmaceutical Industry"

Transcription

1 Opportunities, Challenges and Benefits of using HACCP as a Quality Risk Management Tool in the Pharmaceutical Industry Saurabh Dahiya 1,, Roop K. Khar 1 and Aruna Chhikara 2 1 Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi , India 2 Department of Chemistry, Dyal Singh College (University of Delhi), Lodhi Road, New Delhi , India Summary Effective quality risk management can facilitate better and more informed decisions, provide regulators with greater assurance of a company s ability to deal with potential risks and can beneficially affect the extent and level of direct regulatory oversight. The Hazard Analysis and Critical Control Points (HACCP) method is now a recognized and useful tool in the pharmaceutical industry to meet the primary principles of quality risk management. Global perspective, forward-looking view, open communication, integrated management, continuous process, shared product vision and teamwork are the principles, which provide a framework to accomplish effective risk management. The quality risk management process includes risk identification, risk analysis and risk evaluation. Control and reduction of the risk focuses on processes for mitigation or avoidance of quality risk when it exceeds an acceptable level. The quality risk management tools provide documented, transparent and reproducible methods to accomplish the steps of the quality risk management process. The HACCP methodology aims to prevent known hazards and reduce the risk that they will occur at specific points in the pharmaceutical manufacturing processes. It covers both the Good Manufacturing Practices (GMP) and the safety of the personnel engaged in the manufacturing processes. HACCP is the systematic method (comprised of seven principles) for the identification, assessment and control of safety hazards associated with physical, chemical and biological hazards. The problems associated with the implementation of HACCP may be overcome by training and education in the HACCP system for the personnel engaged in pharmaceutical industry. The HACCP system benefits all, the consumers, industry and the government as it focuses on prevention rather than relying mainly on end product testing. This scientific and systematic system is cost-effective and leads to reduced product loss *Correspondence to: Saurabh Dahiya, Research Scholar, Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi , India. saurabhdahiya@gmail.com Copyright r 2009 John Wiley & Sons, Ltd. Qual Assur J 2009; 12,

2 96 S. Dahiya et al. and wastage, and assures the safety of pharmaceutical products. Copyright r 2009 John Wiley & Sons, Ltd. Key Words: Hazard Analysis and Critical Control Points (HACCP); quality risk management; Good Manufacturing Practices; GMP; Critical Control Point (CCP); risk analysis Introduction It is commonly understood that risk is defined as the combination of the probability of occurrence of harm and the severity of that harm. The manufacturing and use of a drug (medicinal) product, including its components, necessarily entail some degree of risk. The risk to its quality is just one component of the overall risk. It is important to understand that product quality should be maintained throughout the product lifecycle such that the attributes that are important to the quality of drug (medicinal) product remain consistent with those used in the specifications in the marketing authorization. Use of quality risk management can improve decision making if a quality problem arises. Effective quality risk management can facilitate better and more informed decisions, can provide regulators with greater assurance of a company s ability to deal with potential risks and can beneficially affect the extent and level of direct regulatory oversight. Principles of Quality Risk Management The primary principles of quality risk management are [1]: The evaluation of the risk to quality should ultimately link back to the protection of the patient. The level of effort, formality and documentation of the quality risk management process should be commensurate with the level of risk and be based on scientific knowledge. In order to guarantee the consistently high quality of medical products for human use, it is absolutely necessary that flawless hygiene conditions be maintained by the strict observance of hygiene rules. With the growing understanding of the impact of process conditions on the quality of the resulting product, process controls (surveillance) have gained increasing importance to complete the quality profile traditionally defined by post-process product testing. Today, process controls have become an important GMP requirement for the pharmaceutical industry. However, before quality process controls can be introduced, the manufacturing process has to be analyzed, with the focus on its critical quality-influencing steps [2]. The Hazard Analysis and Critical Control Points (HACCP) method is well recognized as a useful tool in the pharmaceutical industry. Although a systematic approach to a quality risk management is generally preferred, it is neither always appropriate nor necessary to use a formal risk management process. The use of informal risk management processes can also be acceptable. Appropriate use of quality risk management can facilitate but does not obviate industry s obligation to comply with regulatory requirements and does not replace appropriate communications between industry and regulators. The seven principles given below in tabular form provide a framework to accomplish effective risk management. These principles are embodied within risk management tools and services like HACCP that address the need to establish a baseline set of risks in a project or programme and the need to create and implement a continuous process by including all parts of the program in the joint management of risks. The seven principles given in Table 1 provide a framework to accomplish effective risk management [3]. Genesis and Growth of Quality Risk Management Process Quality risk management includes systematic processes designed to coordinate, facilitate and

3 Opportunities, Challenges and Benefits of using HACCP 97 Table 1. Seven principles providing the framework to accomplish effective risk management [3] Global Perspective Forwardlooking View Open Communication Integrated Management Continuous Process Shared Product Vision Teamwork Viewing all product and process development work with in the context of the larger systems-level definition, design, and development. Recognizing both the potential value of opportunity and the potential impact of adverse effects. Thinking toward tomorrow, identifying uncertainties, anticipating potential outcomes. Managing project resources and activities while anticipating uncertainties. Encouraging free-flowing information at and between all project levels. Enabling formal, informal, and impromptu communication. Using processes that value the individual voice (bringing unique knowledge and insight to identifying and managing risk). Making risk management an integral and vital part of project management. Adapting risk management methods and tools to a project s infrastructure and culture. Sustaining constant vigilance. Identifying and managing risk routinely through all phases of the project s life cycle. Mutual product vision based on common purpose, shared ownership, and collective communication. Focusing on results. Working cooperatively to achieve common goal. Pooling talents, skills, and knowledge. improve science-based decision making with respect to risk. Possible steps used to initiate and plan a quality risk management process might include the following: Define the problem and/or risk question including pertinent assumptions identifying the potential for risk. Assemble background information and data on the potential hazard, harm or human health impact relevant to the risk assessment. Define how decision makers will use the information, assessment and conclusions. Identify a leader and necessary resources. Specify a timeline and deliverables for the risk management process. The steps include risk identification, risk analysis and risk evaluation. Quality risk assessments begin with a well-defined problem description or risk question. What might go wrong? What is the likelihood (probability) it will go wrong? What are the consequences (severity)? Identification of the risk involves a systematic use of information to identify hazards referring to the risk question or problem description. Information can include historical data, theoretical analysis, informed opinions, and the concerns of stakeholders. Risk identification addresses the What might go wrong? question, including identifying the possible consequences. This provides the basis for further steps in the quality risk management process. The analysis of risk includes the process of estimation of the risk associated with the identified hazards. It is the process that focuses on the second and third question, seeking the likelihood that risks identified in risk identification might occur and the ability to detect them. Finally the evaluation process compares the identified and analyzed risk against given risk criteria. A qualitative or quantitative process might be used to assign the probability and severity of a risk. Risk evaluations consider the strength of evidence for all three of the fundamental questions. Control and reduction of the risk focuses on decision making to reduce and/or accept risks. The purpose of risk control is to reduce the risk to an acceptable level, while risk reduction focuses on processes for mitigation or avoidance of quality risk when it exceeds an acceptable level. Risk reduction might include actions taken to mitigate the severity and probability of harm. Exchange or sharing of information about risk and its management between the decision maker and other involved parties constitutes the risk communication

4 98 S. Dahiya et al. process. The involved parties can communicate at any stage of the risk management process. Also a formal risk communication process may be developed as part of the risk management process. Once a quality risk management process has been initiated, that process should then be continued, reviewed and utilized for events that might impact the original quality of the product and processes. Figure 1 presents the quality risk management process. Risk Management Tools Quality risk management tools support a scientific and practical approach to decision making by providing documented, transparent and reproducible methods to accomplish steps of the quality risk management process. Failure Mode Effects Analysis (FMEA). Failure Mode Effects and Criticality Analysis (FMECA). Fault Tree Analysis (FTA). Hazard Analysis and Critical Control Points (HACCP). Hazard Operability Analysis (HAZOP). Preliminary Hazard Analysis (PHA). Risk ranking and filtering. Supporting statistical tools. Basic Risk Management Facilitation Methods Some of the simple techniques that are commonly used to structure risk management by organizing data and facilitating decisionmaking are: Flowcharts. Check Sheets. Process Mapping. Cause and Effect Diagrams (also called an Ishikawa diagram or fish bone diagram). Figure 1. Presentation of the quality risk management process [1]

5 Opportunities, Challenges and Benefits of using HACCP 99 Hazard Analysis and Critical Control Points (HACCP) HACCP is a systematic, proactive and preventive method for assuring product quality, reliability, and safety [4]. It is a structured approach that applies technical and scientific principles to analyze, evaluate, prevent, and control the risk or the adverse consequence(s) of hazard(s) due to the design, development, production, and use of products. This is a method which in effect seeks to plan out unsafe practices, differing from traditional produce and test quality control methods. Hazard Analysis and Critical Control Point (HACCP) methodology has been considered to be a food safety management system. It aims to prevent known hazards and to reduce the risks that they will occur at specific points in the food chain. The same principles are also increasingly being applied in other industries also. Hazards affecting quality are controlled to a certain extent through the validation of critical operations and processes in the manufacture of finished pharmaceutical products in accordance with Good Manufacturing Practices (GMP). However GMP does not cover the safety of the personnel engaged in manufacture, while safety and quality aspects are covered by HACCP [5 9]. Procedures, including GMP, address optional conditions and provide the basis for HACCP. HACCP is the systematic method for the identification, assessment and control of safety hazards. Such hazards are defined as biological, chemical, or physical agents or operations that are reasonably likely to cause illness or injury if not controlled. In the manufacture of pharmaceuticals [5], these may include the manufacture of certain antibiotics, hormones, cytotoxic substances or other highly active pharmaceuticals, together with operations such as fluid-bed drying and granulation, which are examples of hazard unit operations. The use of inflammable solvents (solutions) and certain laboratory operations may also constitute hazards. Historical Background of HACCP HACCP programs first began as a natural extension of GMPs that food companies had been using as a part of their normal operations. A system was needed that enabled the production of safe, nutritional products for use by the National Aeronautics and Space Administration (NASA) starting in the late 1950s to feed future astronauts. Food products could not be recalled or replaced while in space [10]. Beginning in 1959, the Pillsbury Company embarked on work with NASA to further develop a process stemming from ideas employed in engineering system development know as Failure Mode and Effect Analysis (FMEA). Through the thorough analysis of production processes and identification of microbial hazards that were known to occur in the production establishment, Pillsbury and NASA identified the critical points in the process at which these hazards were likely introduced into product and therefore should be controlled. The establishment of critical limits of specific mechanical or test parameters for control at those points, the validation of these prescribed steps by scientifically verifiable results, and the development of record keeping by which the processing establishment and the regulatory authority could monitor how well process control was working all culminated in what today is known as HACCP. In this way, an expensive or time-consuming testing procedure is not required to guarantee the safety of each piece of food leaving an assembly line, but rather the entire process has been seamlessly integrated as a series of validated steps. In 1971, the HACCP approach was presented at first American National Conference for Food Protection. From 1988 to the present day, HACCP principles have been promoted and incorporated into food safety legislation in many countries around the world. Beginning in 1996, the United States Department of Agriculture (USDA) established a

6 100 S. Dahiya et al. detailed Pathogen Reduction/Hazard Analysis of Critical Control Point (PR/HACCP) program under the Food Safety and Inspection Service (FSIS) to regulate the production of raw meat products by large-scale facilities [10]. Seven Principles for Achieving HACCP Management a) Conduct a hazard analysis and identify preventive measures for each step of the process. b) Determine the critical control points. c) Establish critical limits. d) Establish a system to monitor the critical control points. e) Establish the corrective action to be taken when monitoring indicates that the critical control points are not in a state of control. f) Establish system to verify that the HACCP system is working effectively. g) Establish a record-keeping system. Potential Areas of Use HACCP might be used to identify and manage risks associated with physical, chemical and biological hazards (including microbiological contamination). HACCP is most useful when product and process understanding is sufficiently comprehensive to support identification of critical control points. The output of a HACCP analysis is a risk management tool that facilitates monitoring of critical points in the manufacturing process [1]. Figure 2 is representative of the principles of HACCP for the food industry and the same type of program can be adapted for pharmaceutical industries as well [7]. How to Implement the HACCP Program in the Pharmaceutical Industry 1 Assemble a HACCP Team The pharmaceutical manufacturer should assure that product-specific knowledge and expertise are available for the development of an effective HACCP plan. This may be best accomplished by assembling a multidisciplinary team. Team members should therefore represent all the relevant disciplines, such as research and development, production, quality control, quality assurance, microbiology, engineering and distribution or others as applicable [5]. Team members should have specific knowledge and expertise regarding the product and process. Where such expertise is not available on site, expert advice should be obtained from other sources. Team members should be able to: a) Conduct a hazard analysis. b) Identify potential hazards. c) Identify hazards that should be controlled. d) Recommend controls and critical limits. e) Devise procedures for monitoring and verification. f) Recommend appropriate corrective action where deviations occur. g) Verify the HACCP plan. 2 Describe the Product and Process A full description of the product and the process should be drawn up, including relevant quality information such as the composition, physical/chemical properties, structure, ph, temperatures, method of cleaning, bactericidal/ bacteriostatic treatments (e.g. heat-treatment), drying, screening, mixing, blending, packaging, and the storage conditions. The method of distribution and transport should also be described, especially where products are thermolabile. 3 Identify the Intended Use The intended use should be based on the expected uses of the product by the end user or consumer. In specific cases, vulnerable population groups, e.g. geriatric patients, infants and immunocompromised patients, may have to be considered.

7 Opportunities, Challenges and Benefits of using HACCP 101 Analyze Hazards Recognize potential hazards to the food s safety. Identify measures to regulate and control the hazard. Identification of Critical Control Points (CCPs) Establish CCPs throughout the production process of the product. CCP Prevention Measures Establish a prevention measure at all CCPs. For example, monitor minimal cooking time or temperature at a certain point in the product line. Monitoring of CCP Prevention Measures Establish a system to monitor prevention measures at a CCP. For example, use a computer system to monitor and log the temperature. CCP Not Met Establish a precaution when the CCP has not been met. For example, if the temperature is too low, the computer will alarm, flagging the batch to be destroyed. HACCP & CCP Log Maintain a log system of all CCPs. Keep records of CCP control methods and action taken to correct potential problems. Figure 2. Principles of HACCP for the food industry (the same type of program can be adapted for pharmaceutical industries as well) 4 Prepare a Figure The figure should be constructed by the HACCP team and should cover all operations and decisions in a process. When applying HACCP to a given operation, the steps preceding and following that operation should also be considered. The HACCP team should confirm the processing operation against the figure during all stages and hours of operation. Amendments to the figure may be made where appropriate, and should be documented. Implementing the Principles of HACCP Principle 1. Conduct a hazard analysis and identify preventive measures for each step of the process. A thorough hazard analysis is required to ensure an effective control point. A two-stage hazard analysis is recommended. During the first stage, the team should review the material, activities, equipment, storage, distribution and intended use of the product. A list of potential hazards (biological, chemical and physical) which may be introduced, increased or controlled in each step should be drawn up. In the hazard analysis, the following should be included wherever possible: a) The probable occurrence of hazards and the severity of their adverse health effects. b) The qualitative and/or quantitative evaluation of the presence of hazards.

8 102 S. Dahiya et al. c) The survival or multiplication of microorganisms of concern. d) The production or persistence in drugs of toxins, chemicals or physical agents. e) The conditions leading to the above. During the second stage, a hazard evaluation should be conducted, i.e. the severity of the potential hazards and the probability of their occurrence should be estimated. The team should then decide which potential hazards should be addressed in the HACCP plan, and what control measures, if any, exist that can be applied for each hazard. More than one control measure may be required to control a specific hazard(s) and more than one hazard may be controlled by a specified control measure. Potential hazards in relation to at least the following should be considered: materials and ingredients, physical characteristics and composition of the product, processing procedure, microbial limits, and, where applicable, premises, equipment packaging, sanitation and hygiene, personnel, risk of explosions, and mix-ups. Principle 2. Determine the critical control points. If a hazard has been identified at a step where control is necessary for safety, and no control measure exists at that step, or any other, the product or process should be modified at that step, or at an earlier or later stage, to include such a control measure. A Critical Control Point (CCP) in the HACCP system can be more easily determined by the use of a decision-tree, which facilitates a logical approach. Principle 3. Establish critical limits. The criteria used for establishing the critical limits often include measurements of temperature, time, moisture level, ph, and sensory parameters, such as visual appearance and texture. Critical limits should be scientifically justified. Principle 4. Establish a system to monitor the critical control points. Monitoring is the scheduled measurement or observation of a CCP relative to its critical limits. Monitoring activities should be recorded. The monitoring procedures used must be able to detect loss of control at the CCP, and this information should ideally be available in time to make adjustments to ensure control of process and prevent violations of the critical limits. Most monitoring procedures for CCPs will need to be done rapidly because they relate to on-line processes and there will not be time for lengthy analytical testing. For this reason, physical and chemical measurements are often preferred to microbiological tests because they can be done rapidly and can often indicate the microbiological control of the product. The personnel conducting the monitoring of CCPs and control measures should be engaged in production (e.g. line supervisors, maintenance staff) and, where appropriate, staff from quality control. They should be trained in monitoring procedures. Principle 5. Establish the corrective actions to be taken. Specific corrective actions should be developed for each CCP in the HACCP system in order to deal with deviations when they occur. These actions should ensure that the CCP is brought under control. Corrective actions should include at least the following: a) Determination and correction of the cause of non-compliance. b) Determination of the disposition of the non-compliant product. c) Recording of the corrective actions that have been taken. Principle 6. Establish a system to verify that HACCP is working effectively. Verification and auditing methods, procedures and tests, including random sampling and analysis, can be used to determine whether the HACCP system is working correctly. The frequency of verification should be sufficient to confirm the proper functioning of the HACCP system. Examples of verification activities include the following: a) Review of the HACCP system and its records.

9 Opportunities, Challenges and Benefits of using HACCP 103 b) Review of deviations and product dispositions. c) Confirmation that CCPs are kept under control. Principle 7. Establish a record keeping system. Documentation and record keeping are essential parts of the HACCP system and should be appropriate to the nature and size of the operation. Examples of activities for which documentation is required include hazard analysis, CCP determination, HACCP plan and critical limit determination. Examples of activities for which records are required include CCP monitoring activities, process steps, associated hazards, critical limits, verification procedures and schedule, and modifications to the HACCP system. Problems Associated With the Implementation of HACCP Pharmaceutical companies, small and medium in size may face problems in implementation of HACCP programme because of insufficient trained personnel. The cost of implementation of the HACCP system in small and medium companies is very high and their small purchasing power cannot often bear it and also cannot exert sufficient influence on their suppliers to start using the HACCP system and the power that they can exert over clients is also limited [11]. Training and Education in the HACCP System HACCP is a relatively new concept in the pharmaceutical industry. Training of personnel in industry, government and universities in HACCP principles and applications is essential for its effective implementation. In developing specific training to support a HACCP plan, working instructions and procedures should be drawn up which define the tasks of the operating personnel to be stationed at each critical control point. Specific training should be provided in the tasks of employees monitoring each CCP. Employees must understand what HACCP is, learn the skills necessary to make it function properly, and must be given the materials and equipment necessary to control the CCPs. Advantages of HACCP Implementation in Pharmaceutical Industry The HACCP system identifies probable hazards to ensure drug safety. It is cost-effective and leads to reduced product loss and wastage. It increases the effectiveness of the quality system by focusing on the critical parts of the process. Its focus is on prevention rather than relying mainly on end product testing. It can aid inspection by regulatory authorities and promote international trade by increasing confidence in drug safety and promote the stability of the business. It complements and strengthens other quality management systems [11]. Conclusion HACCP would enable the producers, processors, distributors, and exporters etc. of pharmaceutical products to utilize technical resources efficiently and in a cost-effective manner in assuring safety of pharmaceutical products. Regulatory inspections and audits would be more systematic and therefore hasslefree. It would no doubt involve deployment of some additional finances initially but this would be more than compensated in the long run through consistently better quality and hence better prices and returns. References 1. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Draft Consensus

10 104 S. Dahiya et al. Guideline Q9 Quality Risk Management, released for construction at step 2 of the ICH Process on 22 March 2005 by the ICH Steering Committee. 2. Jahnke M, Kuhn KD. Use of hazard analysis and critical control points (HACCP) risk assessment on a medical device for parenteral application, 1: PDA. J Pharm Sci Technol 2003; 57(1): The Principles of Risk Management. Available at last accessed 28 July WHO Technical Report Series No 908, 2003 Annex.7 5. World Health Organization. Quality Assurance of Pharmaceuticals. A Compendium of Guidelines and Related Materials, Volume 2. Geneva, International Labour Organization. Major Hazard Control: A practical manual. An ILO contribution to the international programme on chemical safety of UNEP, ILO, WHO (IPCS). Geneva, first edition 1988; third impression (with corrections) World Health Organization. HACCP: Introducing the Hazard Analysis and Critical Control Point System. Geneva, 1997 (document WHO/FSF/FOS/97.2). 8. World Health Organization. Quality Assurance of Pharmaceuticals. A Compendium of Guidelines and Related Materials, Volume 1. Geneva, World Health Organization. Quality Assurance of Pharmaceuticals. A Compendium of Guidelines and Related Materials, Volume 2: Good Manufacturing Practices and Inspection. Geneva, Hazard Analysis and Critical Control Points. Available at last accessed 28 July Maria Isabel Virgílio Omar. HACCP Training Manual, page 4. United Nations University Fisheries Training Programme, Reykjavik, Iceland, Available at %20Isabel-haccp4finalreport1.pdf; last accessed 28 July 2009.

WHO guidelines on quality risk management

WHO guidelines on quality risk management Annex 2 WHO guidelines on quality risk management 1. Introduction 62 1.1 Background and scope 62 1.2 Principles of quality risk management 64 2. Glossary 67 3. Quality risk management process 70 3.1 Initiating

More information

CGMP for 21 st Century : A Risk-based Approach (Quality by Design)

CGMP for 21 st Century : A Risk-based Approach (Quality by Design) CGMP for 21 st Century : A Risk-based Approach (Quality by Design) Chung Keel Lee, Ph.D. Special Advisor to the Minister, MFDS Professor, EWU/SNU Advisor, WHO Chair, ISPE Korea 4Ms Four Basic Elements

More information

Quality Risk Management

Quality Risk Management Quality Risk Management Audit Expectations and Observations Matthew Davis Lead Auditor Office of Manufacturing Quality, TGA CAPSIG 4 th May 2011 www.tga.gov.au 2 QRM - TGA Expectations and Observations

More information

Systematic Risk Management: An Overview of ICH Q-9

Systematic Risk Management: An Overview of ICH Q-9 Systematic Risk Management: An Overview of ICH Q-9 March 12, 2014 12014 ParagonRx International LLC Today s Session Systematic Risk Management: An Overview of ICH Q-9 Speakers: Jeff Fetterman, President,

More information

THE BASIC PRINCIPLES OF HACCP

THE BASIC PRINCIPLES OF HACCP THE BASIC PRINCIPLES OF HACCP The Meaning of HACCP History of the HACCP System Traditional Inspection HACCP System The Seven Principles of HACCP ١ Meaning of HACCP : Hazard Analysis and Critical Control

More information

RISK ASSESSMENT IN PHARMACEUTICAL MICROBIOLOGY

RISK ASSESSMENT IN PHARMACEUTICAL MICROBIOLOGY RISK ASSESSMENT IN PHARMACEUTICAL MICROBIOLOGY Ivana Jovanovska-Klincarska 1*, Ilina Popovska 1, Vladimir Kostovski 1, Jelena Dimitrovska 1, Ema Kikovska-Stojanovska 1, Sonja Ugarkovic 1 1 Research and

More information

HACCP Principles & Application Guidelines

HACCP Principles & Application Guidelines 1 U.S. Food and Drug Administration Protecting and Promoting Your Health HACCP Principles & Application Guidelines Adopted August 14, 1997 NATIONAL ADVISORY COMMITTEE ON MICROBIOLOGICAL CRITERIA FOR FOODS

More information

Risk Management: FDA and Industry Experience. Dan Snider, Ph.D Vice President Morgantown RD Mylan Pharmaceuticals Inc.

Risk Management: FDA and Industry Experience. Dan Snider, Ph.D Vice President Morgantown RD Mylan Pharmaceuticals Inc. Risk Management: FDA and Industry Experience Dan Snider, Ph.D Vice President Morgantown RD Mylan Pharmaceuticals Inc. Disclaimer This presentation contains a summary of the opinion and perspective from

More information

Hazard Analysis and Critical Control Point The Almond Board of California. Overview. Definitions

Hazard Analysis and Critical Control Point The Almond Board of California. Overview. Definitions Hazard Analysis and Critical Control Point The Almond Board of California Overview Hazard Analysis Critical Control Point (HACCP) is the final stage of an integrated, proactive food safety program targeting

More information

ISO 22000:2005 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005

ISO 22000:2005 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005 SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005 WWW.SYSTEMKARAN.ORG 1 www.systemkaran.org Foreword... 6 Introduction... 7 Food safety management systems Requirements

More information

Quality Risk Management & food safety management

Quality Risk Management & food safety management Quality Risk Management & food safety management by Tina Beck Hansen Quality Risk Management (http://www.ich.org/fileadmin/public_web_site/ich_pro ducts/guidelines/quality/q9/step4/q9_guideline.pdf) ICH

More information

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS ISO 22000:2005 Standard Food Safety Management System INTERNATIONAL STANDARDS REGISTRATIONS 3.1 FOOD SAFETY concept that food will not cause harm to the consumer when it is prepared and/or eaten according

More information

Special aspects of European Ordinances regarding Cleaning and Disinfection in Food Premises

Special aspects of European Ordinances regarding Cleaning and Disinfection in Food Premises Module 6 Special aspects of European Ordinances regarding Cleaning and Disinfection in Food Premises This project has been funded with support from the European Commission. This publication [communication]

More information

Principles and Guidelines for the Conduct of Microbiological Risk Assessment

Principles and Guidelines for the Conduct of Microbiological Risk Assessment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Introduction Risks from microbiological hazards are of immediate and serious concern to human health. Microbiological Risk Analysis is a science-based structured

More information

PRINCIPLES AND GUIDELINES FOR THE CONDUCT OF MICROBIOLOGICAL RISK ASSESSMENT CAC/GL Adopted Amendments 2012, 2014.

PRINCIPLES AND GUIDELINES FOR THE CONDUCT OF MICROBIOLOGICAL RISK ASSESSMENT CAC/GL Adopted Amendments 2012, 2014. PRINCIPLES AND GUIDELINES FOR THE CONDUCT OF MICROBIOLOGICAL RISK ASSESSMENT CAC/GL 30-1999 Adopted 1999. Amendments 2012, 2014. CAC/GL 30-1999 2 1. INTRODUCTION 2. SCOPE 3. DEFINITIONS 4. GENERAL PRINCIPLES

More information

Risk Based Validation. Why, How and with what tools?

Risk Based Validation. Why, How and with what tools? Risk Based Validation Why, How and with what tools? Tech Talk Agenda History of FDA GMP initiative for the 21 st Century. Industry response to FDA initiative. Harmonisation through ICH. ASTM Standard on

More information

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation

More information

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern

More information

2. Risk-based compliance was also a key component in the FDA's new approach for dealing with electronic records and signatures: 21 CFR Part 11.

2. Risk-based compliance was also a key component in the FDA's new approach for dealing with electronic records and signatures: 21 CFR Part 11. LITERATURE REVIEW: Risk management is well known and practiced in many industries and several industry task forces have developed guidance documents that facilitate risk management. Risk management for

More information

Code of Practice: Processing of Seafood Product. Part 3: HACCP Application, and the Identification of Other Risk Factors and their Controls

Code of Practice: Processing of Seafood Product. Part 3: HACCP Application, and the Identification of Other Risk Factors and their Controls Code of Practice: Processing of Seafood Product Part 3: HACCP Application, and the Identification of Other Risk Factors and their Controls July 2011 Introduction Disclaimer Every effort has been made to

More information

COMPARING THE STANDARDS

COMPARING THE STANDARDS COMPARING THE STANDARDS Codex/NACMCF Preventive Rule BRC Comparison 2.0 FUNDAMENTAL Preparatory stages 1 - Assemble the team The team: ideally should be multidisciplinary can use outside expert help should

More information

Identification and Control of Critical Process Points Using Complementary Risk Assessments (corrected)

Identification and Control of Critical Process Points Using Complementary Risk Assessments (corrected) Identification and Control of Critical Process Points Using Complementary Risk Assessments (corrected) Karen McCullough MMI Associates (908) 534-6463 PDA Metro Chapter Day June 2, 2009 RISK is a four letter

More information

Public Health Consumer Protection Program

Public Health Consumer Protection Program Public Health Consumer Protection Program Date Dear Facility Name Thank you for your interest in developing a Hazard Analysis Critical Control Point (HACCP) plan. When you have compiled your completed

More information

Creating Hazard Analysis and Critical Control Point (HACCP) Plans that are FSIS-Compliant

Creating Hazard Analysis and Critical Control Point (HACCP) Plans that are FSIS-Compliant Creating Hazard Analysis and Critical Control Point (HACCP) Plans that are FSIS-Compliant Every meat and poultry processor in the United States must create a Hazard Analysis and Critical Control Point

More information

Q10 PHARMACEUTICAL QUALITY SYSTEM

Q10 PHARMACEUTICAL QUALITY SYSTEM Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights

More information

APPENDIX K. HACCP PROGRAM

APPENDIX K. HACCP PROGRAM APPENDIX K. HACCP PROGRAM I. THE HACCP SYSTEM INTRODUCTION HISTORY OF HACCP: The use of the HACCP System is not new to the dairy industry. HACCP is a logical, simple, effective, but highly structured system

More information

QUALITY RISK MANAGEMENT (QRM) TOOLKIT

QUALITY RISK MANAGEMENT (QRM) TOOLKIT QUALITY RISK MANAGEMENT (QRM) TOOLKIT Amanda Bishop McFarland Senior Continuous Process Improvement Analyst Global Quality Risk Management Genzyme, A Sanofi Company Disclaimers The material and perspectives

More information

UNIT 10 CLAUSE-WISE INTERPRETATION OF ISO 22000: 2005

UNIT 10 CLAUSE-WISE INTERPRETATION OF ISO 22000: 2005 ISO 22000:2005 UNIT 10 CLAUSE-WISE INTERPRETATION OF ISO 22000: 2005 Structure 10.0 Objectives 10.1 Introduction 10.2 Clause-wise Explanation of the Standard 10.2.1 Clause 1: Scope 10.2.2 Clause 2: Normative

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

Risk Management from the Point of View of a Competent Authority

Risk Management from the Point of View of a Competent Authority Risk Management from the Point of View of a Competent Authority Rudolf Völler GMP Inspectorate, Regierungspräsidium, Darmstadt (Germany) Summary A working risk evaluation system is a key element of drug

More information

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Guidelines for Process Validation of Pharmaceutical Dosage Forms Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical

More information

Improved Food Inspection Model The Case for Change

Improved Food Inspection Model The Case for Change Improved Food Inspection Model The Case for Change DRAFT The Improved Food Inspection Model: The Case for Change 1 Purpose of this paper DRAFT The Improved Food Inspection Model: The Case for Change The

More information

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible

More information

Robert Posgai Director of Materials Procurement, Biogen (BPOG)

Robert Posgai Director of Materials Procurement, Biogen (BPOG) Keynote Speaker Building the Foundations for Excellence in Biopharmaceutical Raw Material Supply Chain and Impact of Modality on Excipient Expectations Robert Posgai Director of Materials Procurement,

More information

2014/SCSC/WKSP1/004 Introduction to Risk-Based Food Inspection

2014/SCSC/WKSP1/004 Introduction to Risk-Based Food Inspection 2014/SCSC/WKSP1/004 Introduction to Risk-Based Food Inspection Submitted by: FAO Workshop on Improved Food Inspection Capacity Building Based on Risk Analysis Seoul, Korea 21-23 May 2014 Introduction to

More information

Use of Microbial Data for Hazard Analysis and Critical Control Point Verification Food and Drug Administration Perspective

Use of Microbial Data for Hazard Analysis and Critical Control Point Verification Food and Drug Administration Perspective 810 Journal of Food Protection, Vol. 63, No. 6, 2000, Pages 810 814 Use of Microbial Data for Hazard Analysis and Critical Control Point Verification Food and Drug Administration Perspective JOHN E. KVENBERG*

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

UR Startup Inc. ISO Audit Checklist. conducted for. Conducted on (Date and Time) 02 Aug :06 PM. Inspected by Andy Dion

UR Startup Inc. ISO Audit Checklist. conducted for. Conducted on (Date and Time) 02 Aug :06 PM. Inspected by Andy Dion ISO 22000 Audit Checklist conducted for UR Startup Inc. Conducted on (Date and Time) 02 Aug 2018 03:06 PM Inspected by Andy Dion Location Chemin de sous le Clos 16 1232 Confignon Switzerland (46.1758650103172,

More information

Quality Implementation Working Group on Q8, Q9 and Q10 Questions & Answers

Quality Implementation Working Group on Q8, Q9 and Q10 Questions & Answers INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Quality Implementation Working Group on Q8, Q9 and Q10 & Current version dated June

More information

SQF Food Safety Code for Manufacturing Changes from Edition 7 to Edition 8

SQF Food Safety Code for Manufacturing Changes from Edition 7 to Edition 8 All changes are highlighted in yellow. SQF System Elements for Food Safety Code for Manufacturing Edition 7 Edition 8 Comments 2.1 Management Commitment 2.1 Management Commitment 2.1.1 Management Policy

More information

HACCP audit checklist

HACCP audit checklist Requirement HACCP audit checklist Prerequisite Program Management Commitment 1. Senior management ensures that the responsibilities and authorities are defined and communicated within the company Internal

More information

SQF 2000 Food Safety Management System Implementation Workbook

SQF 2000 Food Safety Management System Implementation Workbook This comprehensive SQF 2000 Food Safety and Quality Management System package contains everything you will need to achieve SQF 2000 Certification. We have written this workbook to assist in the implementation

More information

SUPPLIER FOOD SAFETY ASSURANCE

SUPPLIER FOOD SAFETY ASSURANCE Chapter 12 SUPPLIER FOOD SAFETY ASSURANCE 1.0 PARTS OF A SUPPLIER FOOD SAFETY ASSURANCE PROGRAM 2.0 CHOOSING SUPPLIERS 2.1 Supplier Approval 2.2 Approved Supplier List 3.0 PRODUCT SPECIFICATIONS AND CONTROLS

More information

ROLE OF ICH GUIDELINES IN PHARMACEUTICAL QUALITY RISK MANGAMENT- REVIEW

ROLE OF ICH GUIDELINES IN PHARMACEUTICAL QUALITY RISK MANGAMENT- REVIEW ejpmr, 2016,3(7), 161-169. SJIF Impact Factor 3.628 Review Article EUROPEAN JOURNAL European OF PHARMACEUTICAL Journal of Pharmaceutical and Medical Research AND MEDICAL RESEARCH ISSN 2394-3211 www.ejpmr.com

More information

ISPE Baseline Pharmaceutical Engineering Guide for New and Renovated Facilities Volume 2: Oral Solid Dosage Forms (Revision) Executive Summary

ISPE Baseline Pharmaceutical Engineering Guide for New and Renovated Facilities Volume 2: Oral Solid Dosage Forms (Revision) Executive Summary Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE September/October 2008, Vol. 28 No. 5 This executive summary provides an overview of the second edition of the ISPE Baseline Guide:

More information

PRODUCT PROTECTION PROGRAM

PRODUCT PROTECTION PROGRAM Chapter 13 PRODUCT PROTECTION PROGRAM 1.0 PREREQUISITE PROGRAMS 2.0 IDENTIFICATION AND CONTROL OF CRITICAL FACTORS 3.0 CRITICAL PROCESSING STEPS AND CRITICAL FACTORS 4.0 MONITORING CRITICAL FACTORS 5.0

More information

SQF 2000 Guidance. Guidance for Food Sector Category 4 Fresh Produce Pack House Operations. 1st Edition

SQF 2000 Guidance. Guidance for Food Sector Category 4 Fresh Produce Pack House Operations. 1st Edition SQF 2000 for Food Sector Category 4 Fresh Produce Pack House Operations 1st Edition SEPTEMBER 2010 Safe Quality Food Institute 2345 Crystal Drive, Suite 800 Arlington, VA 22202 USA 202-220-0635 www.sqfi.com

More information

HACCP AND MEAT AND POULTRY INSPECTION. John W. McCutcheon Associate Deputy Administrator, Field Operations Food Safety and Inspection Service, USDA

HACCP AND MEAT AND POULTRY INSPECTION. John W. McCutcheon Associate Deputy Administrator, Field Operations Food Safety and Inspection Service, USDA Agricultural Outlook Forum February 23, 1998 For Release: Monday, HACCP AND MEAT AND POULTRY INSPECTION John W. McCutcheon Associate Deputy Administrator, Field Operations Food Safety and Inspection Service,

More information

HAZARD ANALYSIS AND CRITICAL CONTROL POINTS FOR WATER SUPPLIES. Kevin Hellier. Melbourne Water Corporation

HAZARD ANALYSIS AND CRITICAL CONTROL POINTS FOR WATER SUPPLIES. Kevin Hellier. Melbourne Water Corporation HAZARD ANALYSIS AND CRITICAL CONTROL POINTS FOR WATER SUPPLIES Paper Presented by : Kevin Hellier Authors: Kevin Hellier, Water Quality Engineer Melbourne Water Corporation 63 rd Annual Water Industry

More information

UNI EN ISO 22000:2005 STANDARD CHECK-LIST

UNI EN ISO 22000:2005 STANDARD CHECK-LIST RINA AUDIT CHECKLIST (Nr.... of...) Audit of the Food Safety Management System Company Production site: Audit type: Preaudit: Stage 1 Stage 2: Surveillance: Recertification: Other:. Report Nr. Date: Auditor:

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

A Step by Step Guide for Preparing a Preventive Control Plan

A Step by Step Guide for Preparing a Preventive Control Plan A Step by Step Guide for Preparing a Preventive Control Plan Introduction Preventive control measures are an internationally accepted approach to prevent or mitigate hazards associated with food products.

More information

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(6):88-98 Conduct of Inspections for Pharmaceutical Manufactures

More information

INTERNATIONAL STANDARD

INTERNATIONAL STANDARD INTERNATIONAL STANDARD ISO 22000 First edition 2005-09-01 Food safety management systems Requirements for any organization in the food chain Systèmes de management de la sécurité des denrées alimentaires

More information

Europe s new approach to assurance of API quality and its implications for manufacturers and producing countries

Europe s new approach to assurance of API quality and its implications for manufacturers and producing countries Europe s new approach to assurance of API quality and its implications for manufacturers and producing countries IPA / EDQM / WHO Mumbai Conference 28 September 2012 Dr Florence Benoit-Guyod, EDQM Inspector,

More information

ICH Q10/WHO TRS A Regulatory Perspective

ICH Q10/WHO TRS A Regulatory Perspective Presentation by: Dr. A. Ramkishan Asst. Drugs Controller (India) Govt. of India ICH Q10/WHO TRS A Regulatory Perspective Contents of Presentation Introduction History of WHO GMP TRS guidelines A Unique

More information

The Role of Quality Risk Management in New Drug Development and Manufacturing

The Role of Quality Risk Management in New Drug Development and Manufacturing The Role of Quality Risk Management in New Drug Development and Manufacturing CASSS CMC Strategy Forum Bethesda, MD July 27, 2009 Terrance Ocheltree, RPh, PhD Pharmaceutical Assessment Lead (Acting) Office

More information

The Food Safety Modernization Act and Its Implications for USDA and Dual Jurisdiction Establishments

The Food Safety Modernization Act and Its Implications for USDA and Dual Jurisdiction Establishments The Food Safety Modernization Act and Its Implications for USDA and Dual Jurisdiction Establishments April 6, 2016 Jolyda Swaim Principal Attorney Olsson Frank Weeda Terman Matz PC jswaim@ofwlaw.com 1

More information

Risk Analysis: myths, confusions and real sense

Risk Analysis: myths, confusions and real sense Risk Analysis: myths, confusions and real sense Dr. Alexander Fedotov, Director of Invar-project Company, Moscow, Russia fedotov@invar-project.ru www.invar-project.ru 1. What is risk analysis? 2. GMP EU

More information

Quality and Safety System for Specialty Feed Ingredients PROCESS DOCUMENT FORMULATION PROCESS VERSION

Quality and Safety System for Specialty Feed Ingredients PROCESS DOCUMENT FORMULATION PROCESS VERSION Quality and Safety System for Specialty Feed Ingredients PROCESS DOCUMENT FORMULATION PROCESS VERSION 2 2017-10-20 Table of Contents 1. Introduction...2 2. Definitions...2 3. HACCP Programme...5 3.1. General

More information

Private Sector Systems for Providing Quality Assurance: From Good Practices to HACCP to Total Quality Management

Private Sector Systems for Providing Quality Assurance: From Good Practices to HACCP to Total Quality Management E. HANAK, E. BOUTRIF, P. FABRE, M. PINEIRO, (Scientific Editors), 2002. Food Safety Management in Developing Countries. Proceedings of the International Workshop, CIRAD-FAO, 11-13 December 2000, Montpellier,

More information

SANCO/1955/2005. Working document: does not necessarily represent the opinion of the European Commission.

SANCO/1955/2005. Working document: does not necessarily represent the opinion of the European Commission. HYG-050-05-A1 EN SANCO/1955/2005 Working document: does not necessarily represent the opinion of the European Commission. Preliminary version: may be subject to changes and amendments. EN EN COMMISSION

More information

inventivhealthclinical.com The Goal: Reducing Uncertainty A Word on RBM

inventivhealthclinical.com The Goal: Reducing Uncertainty A Word on RBM Seeing Around Corners: Risk Assessment Is the Foundation of Risk-Based Monitoring By: Jeff Fetterman, President ParagonRX, an inventiv Health Company, Michael Macri, Director, Strategic Services, inventiv

More information

FSMA Food Safety Seminar Japan External Trade Organization

FSMA Food Safety Seminar Japan External Trade Organization FSMA Food Safety Seminar Japan External Trade Organization U.S. Food and Drug Administration s Risk-Based Preventive Controls for Human Food & Supply Chain Preventive Controls January 2017 Jolyda Swaim

More information

HACCPEUROPA PUBLICATIONS ISO 22000:2005 FOOD SAFETY QUALITY MANUAL. ISO 22000:2005 Quality Manual

HACCPEUROPA PUBLICATIONS ISO 22000:2005 FOOD SAFETY QUALITY MANUAL. ISO 22000:2005 Quality Manual HACCPEUROPA PUBLICATIONS ISO 22000:2005 FOOD SAFETY QUALITY MANUAL ISO 22000:2005 Quality Manual QUALITY MANUAL ISO 22000:2005 Food Safety Management HACCPEuropa Publications 2012 Table of Contents Introduction...

More information

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

Enabling Improvement through the Product Lifecycle: Change Management within a PQS Enabling Improvement through the Product Lifecycle: Change Management within a PQS Denise DiGiulio, Senior Advisor OPQ Office of Process and Facilities PDA Chapter Meeting Melbourne, Australia April 3,

More information

Use of PSA to Support the Safety Management of Nuclear Power Plants

Use of PSA to Support the Safety Management of Nuclear Power Plants S ON IMPLEMENTATION OF THE LEGAL REQUIREMENTS Use of PSA to Support the Safety Management of Nuclear Power Plants РР - 6/2010 ÀÃÅÍÖÈß ÇÀ ßÄÐÅÍÎ ÐÅÃÓËÈÐÀÍÅ BULGARIAN NUCLEAR REGULATORY AGENCY TABLE OF CONTENTS

More information

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9 Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This

More information

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009 European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PH 1/97 (Rev. 3), 15 January 2002 ANNEX 15 QUALIFICATION AND

More information

The short answer is very. Assuring safety in

The short answer is very. Assuring safety in How critical is petfood safety? How critical is petfood The short answer is very. Assuring safety in the petfood industry is critical at all levels: producers, manufacturers and consumers. We are all responsible

More information

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q8, Q9, and Q10 Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information

ICH Q9 An Industry Perspective: Ensuring Quality to Patients in a Risk-Based Regulatory Environment

ICH Q9 An Industry Perspective: Ensuring Quality to Patients in a Risk-Based Regulatory Environment ICH Q9 An Industry Perspective: Ensuring Quality to Patients in a Risk-Based Regulatory Environment Thomas Schultz, Ph.D. Director, Regulatory Sciences Johnson & Johnson September 12, 2007 Presentation

More information

SITE MASTER FILE For MHRA

SITE MASTER FILE For MHRA ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of

More information

Hazard Analysis Critical Control Point BY DR. ADNAN HASAN

Hazard Analysis Critical Control Point BY DR. ADNAN HASAN Hazard Analysis Critical Control Point BY DR. ADNAN HASAN HACCP: The Hazard analysis and critical control point is a scientific system created to identify specific hazards and actions to control them in

More information

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Review Article Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Chagi Venkatesh*, S. B. Puranik ABSTRACT Good practices in quality control (QC) department

More information

CONTENTS 1 INTRODUCTION The Regulatory Focus on Quality Risk Management Objectives of Risk Assessment and Risk Management: The Key Concepts Key Terms in Relation to Risk and Risk Assessment Structure of

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology PharmaTutor PRINT ISSN: 294-6679 E-ISSN: 247-788 2 Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology Upendra Kumar Singh*, Sammer

More information

BRC Food Safety Management System Implementation Workbook

BRC Food Safety Management System Implementation Workbook We have written this workbook to assist in the implementation of your BRC food safety management system. The workbook is divided into 8 steps that are designed to assist you in implementing your food safety

More information

SQF 2000 Code. 6th Edition AUGUST A HACCP-Based Supplier Assurance Code for the Food Manufacturing and Distributing Industries

SQF 2000 Code. 6th Edition AUGUST A HACCP-Based Supplier Assurance Code for the Food Manufacturing and Distributing Industries SQF 2000 Code A HACCP-Based Supplier Assurance Code for the Food Manufacturing and Distributing Industries 6th Edition AUGUST 2008 Safe Quality Food Institute 2345 Crystal Drive, Suite 800 Arlington, VA

More information

Eduarda M. Zandamela Mungói, PhD Food Science

Eduarda M. Zandamela Mungói, PhD Food Science Management of Food Safety risks in relation to Trade in agro-processed products and food Eduarda M. Zandamela Mungói, PhD Food Science 2013-11-21 DEFINITIONS FOR THE PURPOSES OF THE CODEX ALIMENTARIUS

More information

The IPEC Risk Assessment Guide for Pharmaceutical Excipients. Part 1 Risk Assessment for Excipient Manufacturers

The IPEC Risk Assessment Guide for Pharmaceutical Excipients. Part 1 Risk Assessment for Excipient Manufacturers The IPEC Risk Assessment Guide for Pharmaceutical Excipients Part 1 Risk Assessment for Excipient Manufacturers First Version 2017 This document represents voluntary guidance for the pharmaceutical excipient

More information

Update to the Manufacturing Principles for Medicinal Products

Update to the Manufacturing Principles for Medicinal Products Update to the Manufacturing Principles for Medicinal Products Michel Lok, Head of Office Robyn Oatey, GMP Auditor, Medicines Office of Manufacturing Quality Therapeutic Goods Administration Introduction

More information

Principle 6. Verification & Validation

Principle 6. Verification & Validation Principle 6 Verification & Validation Principle #6 - Verification Establish procedures to VERIFY that the HACCP system is working as intended Verification - Defined Those activities, other than monitoring

More information

Code of Practice Processing of Poultry. Part 1: Overview

Code of Practice Processing of Poultry. Part 1: Overview Code of Practice Processing of Poultry December 2007 Page 2 Prelims Prelims December 2007 Table of Contents Prelims...2 1 Purpose and Scope of the Code of Practice...5 2 Requirements of the Animal Products

More information

Quality and Safety System for Specialty Feed Ingredients PROCESS DOCUMENT CHEMICAL PROCESS VERSION

Quality and Safety System for Specialty Feed Ingredients PROCESS DOCUMENT CHEMICAL PROCESS VERSION Quality and Safety System for Specialty Feed Ingredients PROCESS DOCUMENT CHEMICAL PROCESS VERSION 2 2017-10-20 Table of Contents 1. Introduction...2 2. Definitions...2 3. HACCP Programme...5 3.1. General

More information

WHITE PAPER. Food Safety, From Farm to Fork. A Best-Practice Approach to Implementing a Food Safety Management System

WHITE PAPER. Food Safety, From Farm to Fork. A Best-Practice Approach to Implementing a Food Safety Management System WHITE PAPER Food Safety, From Farm to Fork A Best-Practice Approach to Implementing a Food Safety Management System Executive Summary Now, more than ever, all food chain stakeholders are required to demonstrate

More information

BRC Food Safety and Quality Management System

BRC Food Safety and Quality Management System This is an ideal package for Food Manufacturers looking to meet BRC Global Standard for Food Safety (Issue 7 published January 2015) for Food Safety Quality Management Systems. Our 2015 BRC Food Safety

More information

A simplified guide to understanding and using Food Safety Objectives and Performance Objectives

A simplified guide to understanding and using Food Safety Objectives and Performance Objectives A simplified guide to understanding and using Food Safety Objectives and Performance Objectives by The International Commission on Microbiological Specifications for Foods (www.icmsf.org) 9 th November

More information

Application of Quality Risk Management Tools for Cell Therapy Manufacturing

Application of Quality Risk Management Tools for Cell Therapy Manufacturing Application of Quality Risk Management Tools for Cell Therapy Manufacturing 17 th ISCT Annual Meeting May 20, 2011 Jean Stanton Associate Director, Product Quality Management Janssen Supply Chain Conflict/Disclaimer

More information

Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM

Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM DCVMN Workshop, Hyderabad, 4-8 April 2016 G. Somasundaram Associate Director - Technology Management Overview Key Regulatory

More information

ISO INTERNATIONAL STANDARD. Cleanrooms and associated controlled environments Biocontamination control Part 1: General principles and methods

ISO INTERNATIONAL STANDARD. Cleanrooms and associated controlled environments Biocontamination control Part 1: General principles and methods INTERNATIONAL STANDARD ISO 14698-1 First edition 2003-09-01 Cleanrooms and associated controlled environments Biocontamination control Part 1: General principles and methods Salles propres et environnements

More information

While the recognition

While the recognition Designing the Perfect Change Control System Change control systems today are expected to be designed in a way that provides a system to not only document and approve changes, but also to anticipate change

More information

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/

More information

COMMISSION RECOMMENDATION. of XXX. on the audits and assessments performed by notified bodies in the field of medical devices

COMMISSION RECOMMENDATION. of XXX. on the audits and assessments performed by notified bodies in the field of medical devices EUROPEAN COMMISSION Brussels, XXX [ ](2013) XXX draft COMMISSION RECOMMENDATION of XXX on the audits and assessments performed by notified bodies in the field of medical devices (Text with EEA relevance)

More information

Journal home page: RESEARCH ARTICLE

Journal home page:  RESEARCH ARTICLE Journal home page: http://www.journalijiar.com INTERNATIONAL JOURNAL OF INNOVATIVE AND APPLIED RESEARCH RESEARCH ARTICLE QUALITY AUDIT AND GMP INSPECTION OF PHARMACEUTICAL INDUSTRY WITH REFERENCE TO USFDA;

More information